BR112015012138A2 - composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit - Google Patents
composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kitInfo
- Publication number
- BR112015012138A2 BR112015012138A2 BR112015012138A BR112015012138A BR112015012138A2 BR 112015012138 A2 BR112015012138 A2 BR 112015012138A2 BR 112015012138 A BR112015012138 A BR 112015012138A BR 112015012138 A BR112015012138 A BR 112015012138A BR 112015012138 A2 BR112015012138 A2 BR 112015012138A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- kit
- obtaining
- vivo imaging
- vivo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3689DE2012 | 2012-11-30 | ||
| GBGB1300647.3A GB201300647D0 (en) | 2013-01-15 | 2013-01-15 | Crystallization |
| PCT/EP2013/074986 WO2014083113A1 (en) | 2012-11-30 | 2013-11-28 | Crystallization process of tricyclic indole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015012138A2 true BR112015012138A2 (pt) | 2017-07-11 |
Family
ID=54266915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015012138A BR112015012138A2 (pt) | 2012-11-30 | 2013-11-28 | composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10709798B2 (enExample) |
| EP (1) | EP2943195A1 (enExample) |
| JP (1) | JP6280560B2 (enExample) |
| KR (1) | KR20150088802A (enExample) |
| CN (2) | CN104837489A (enExample) |
| AU (1) | AU2013351152A1 (enExample) |
| BR (1) | BR112015012138A2 (enExample) |
| CA (1) | CA2892485A1 (enExample) |
| IN (1) | IN2015DN03978A (enExample) |
| MX (1) | MX2015006871A (enExample) |
| RU (1) | RU2015118217A (enExample) |
| WO (1) | WO2014083113A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2015118217A (ru) | 2012-11-30 | 2017-01-11 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ кристаллизации трициклических индольных производных |
| US20160144477A1 (en) * | 2014-11-21 | 2016-05-26 | Diane Scott | Coated compressive subpad for chemical mechanical polishing |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177440B1 (en) * | 1996-10-30 | 2001-01-23 | Eli Lilly And Company | Substituted tricyclics |
| CA2310250A1 (en) | 1997-11-14 | 1999-05-27 | August Masaru Watanabe | Treatment for alzheimer's disease |
| DZ2769A1 (fr) | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Composés tricycliques substitués. |
| JP2005527466A (ja) | 2001-08-09 | 2005-09-15 | イーライ・リリー・アンド・カンパニー | ｓＰＬＡ２インヒビターとしてのシクロヘプトＢインドール誘導体 |
| WO2003014082A1 (en) | 2001-08-09 | 2003-02-20 | Eli Lilly And Company | Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
| GB0905328D0 (en) * | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
| SG183837A1 (en) * | 2010-03-26 | 2012-10-30 | Ge Healthcare Ltd | Tricyclic indole derivatives as pbr ligands |
| GB201016038D0 (en) | 2010-09-24 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method |
| GB201016411D0 (en) * | 2010-09-30 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method for cancer |
| GB201021263D0 (en) | 2010-12-15 | 2011-01-26 | Ge Healthcare Ltd | Solid phase extraction method |
| US9220795B2 (en) * | 2011-09-22 | 2015-12-29 | Ge Healthcare Limited | Indole derivatives |
| RU2015118217A (ru) | 2012-11-30 | 2017-01-11 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ кристаллизации трициклических индольных производных |
-
2013
- 2013-11-28 RU RU2015118217A patent/RU2015118217A/ru not_active Application Discontinuation
- 2013-11-28 CN CN201380062872.4A patent/CN104837489A/zh active Pending
- 2013-11-28 MX MX2015006871A patent/MX2015006871A/es unknown
- 2013-11-28 IN IN3978DEN2015 patent/IN2015DN03978A/en unknown
- 2013-11-28 CA CA2892485A patent/CA2892485A1/en not_active Abandoned
- 2013-11-28 US US14/648,353 patent/US10709798B2/en active Active
- 2013-11-28 WO PCT/EP2013/074986 patent/WO2014083113A1/en not_active Ceased
- 2013-11-28 KR KR1020157013974A patent/KR20150088802A/ko not_active Withdrawn
- 2013-11-28 BR BR112015012138A patent/BR112015012138A2/pt not_active IP Right Cessation
- 2013-11-28 JP JP2015544462A patent/JP6280560B2/ja active Active
- 2013-11-28 CN CN202010090283.9A patent/CN111362863A/zh active Pending
- 2013-11-28 AU AU2013351152A patent/AU2013351152A1/en not_active Abandoned
- 2013-11-28 EP EP13796090.2A patent/EP2943195A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014083113A1 (en) | 2014-06-05 |
| KR20150088802A (ko) | 2015-08-03 |
| EP2943195A1 (en) | 2015-11-18 |
| RU2015118217A (ru) | 2017-01-11 |
| CN111362863A (zh) | 2020-07-03 |
| AU2013351152A1 (en) | 2015-05-21 |
| CA2892485A1 (en) | 2014-06-05 |
| US20150335766A1 (en) | 2015-11-26 |
| MX2015006871A (es) | 2015-09-16 |
| CN104837489A (zh) | 2015-08-12 |
| US10709798B2 (en) | 2020-07-14 |
| IN2015DN03978A (enExample) | 2015-10-02 |
| JP2016507477A (ja) | 2016-03-10 |
| JP6280560B2 (ja) | 2018-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015022047A8 (pt) | uso de uma composição compreendendo nanopartículas contendo um fármaco da família limo e uma albumina | |
| CO6630147A2 (es) | Modificador del sabor dulce | |
| MX2023006541A (es) | Formulaciones de dosis fija. | |
| MX348823B (es) | Formulaciones estables de linaclotida. | |
| MY157124A (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| PH12012501337A1 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
| MX2015008628A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| BR112013007364A2 (pt) | preparação para melhorar a solubilidade para um fármaco pouco solúvel | |
| PH12013502565A1 (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| WO2011082267A3 (en) | Substituted triazolo-pyrazine compounds | |
| UA109868C2 (ru) | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| MX2013001234A (es) | Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a. | |
| MX362530B (es) | Composiciones de acido hialuronico que comprenden mepivacaina. | |
| WO2011123678A3 (en) | Substituted benzo-pyrido-triazolo-diazepine compounds | |
| WO2013188283A8 (en) | Topical ophthalmological pharmaceutical composition containing sunitinib | |
| WO2015033302A3 (en) | Fulvestrant compositions | |
| PH12012501556A1 (en) | Substituted naphthalenyl-pyrimidine compounds | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| EA201600394A1 (ru) | Трициклические соединения пиперидина | |
| BR112014032254A2 (pt) | processo para a preparação de uma composição, aparelho, e, uso de um aparelho | |
| BR112015012138A2 (pt) | composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit | |
| TN2015000280A1 (en) | Topical Ophthalmological Pharmaceutical Composition containing Regorafenib | |
| WO2012061342A3 (en) | Substituted benzo-imidazo-pyrido-diazepine compounds | |
| WO2014006635A3 (en) | Solid oral compositions of silodosin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |